- Open Access
Angiogenic efficacy of Heparin on chick chorioallantoic membrane
© Rema et al.; licensee BioMed Central Ltd. 2012
- Received: 27 September 2011
- Accepted: 15 March 2012
- Published: 18 April 2012
Heparin is an anticoagulant agent known to have diverse effects on angiogenesis with some reports suggesting that it can induce angiogenesis while a few have indicated of its inhibitory property. Cancer patients treated for venous thromboembolism with low molecular heparin had a better survival than the unfractionated heparin (UFH). Heparin is known to interact with various angiogenic growth factors based on its sulfation modifications within the glycosaminoglycan chains. Therefore it is important to study the mechanism of action of heparin of different molecular weight to understand its angiogenic property. In this concern, we examined the angiogenic response of higher molecular weight Heparin (15 kDa) of different concentrations using late CAM assay. Growth of blood vessels in terms of their length and size was measured and thickness of the CAM was calculated morphometrically. The observed increase in the thickness of the CAM is suggestive of the formation of capillary like structures at the treated region. Analysis of the diffusion pattern showed internalized action of heparin that could affect gene expression leading to proliferation of endothelial cells. Angiogenesis refers to formation of new blood vessels from the existing ones and occurrence of new blood vessels at the treated area strongly confirms that heparin of 15 kDa molecular weight has the ability to induce angiogenesis on CAM vascular bed in a dose dependent manner. The results demonstrate the affinity of heparin to induce angiogenesis and provide a novel mechanism by which heparin could be used in therapeutics such as in wound healing process.
- Chorioallantoic Membrane (CAM)
- Endothelial cells (ECs)
Heparin, a member of the glycosaminoglycan family of carbohydrates found on the cell surface and in the extracellular matrix  has the potential to induce angiogenesis [2, 3]. It was shown to bind both with angiogenic  and anti-angiogenic proteins favoring and stabilizing the association with their respective receptors . Heparin present at the basal site of blood vessels act as matrix receptors by interacting with a variety of basement membrane proteins and is involved in the binding and internalization of lipoprotein lipase on endothelium . Heparin present in the extra cellular matrix (ECM) may act as a reservoir for angiogenic growth factors and will sustain the long-term stimulation of endothelial cells . It was already shown that heparin of different molecular weight could promote angiogenesis  on the chorioallantoic membrane of the chick embryo and introduction of heparin directly into the allantoic sac of CAM  resulted in dilated sinuous arterial and venous branches suggesting that heparin could induce new blood vessel formation. Poly-l-lysine/heparin complexes were found to stimulate angiogenesis in chick embryo chorioallantoic membrane .
We analyzed the angiogenic effect of Heparin (15 kDa) by treating CAM with 3 different concentrations (50, 100 and 150 μM) using gelatin sponges after 72hours of incubation. Biotinylated Heparin contains 5–8 mole-percent biotin and is attached through a 12-atom spacer arm containing a cleavable disulfide group. This has been used mainly to study its localization on CAM using streptavidin labeled with HRP.
Diffusion of Heparin through various layers of CAM and also the morphological changes induced on CAM during treatment was analysed. Thickness of the CAM was also measured to further substantiate the angiogenic response and formation of new blood vessels. Angioquant software was used to measure the growth of the vessels by modifying the macroscopic images taken during treatment period. This software is specially made for quantifying angiogenesis using in vitro assays and has been employed for CAM with some modifications. The results obtained using morphometry and immunostaining of 15 kDa heparin might be of therapeutic significance in angiogenic disorders that requires neovascularisation.
Fertilized White leghorn chicken eggs (gallus gallus) were purchased from, Tamil Nadu Poultry Research Station, Madras Veterinary University, Nandanam, Chennai, India. Gelatin sponges were from Jhonson & Jhonson Pvt Ltd, Heparin from CALBIOCHEM, USA (Product No. 375054), HRP conjugated streptavidin (HRP-anti-rabbit secondary) from Bangalore Genei, India, Phosphate buffered solution and other common reagents were purchased from Sigma, Aldrich, USA.
The in ovo CAM model
Fertilized chicken eggs weighing 50 ± 2gm were incubated at 37°C in a humidified atmosphere (>60% relative humidity) based on protocol for the Hen's Egg Test-Chorioallantoic Membrane (HET-CAM) method. At day 3 of post incubation, 2 to3 ml of albumin was withdrawn, using a 21-gauge needle, through the large blunt edge of the egg in order to minimize adhesion of the shell membrane with CAM. A square window of 1 cm² was opened in the egg shell and sealed with paraffin film to prevent dehydration and the eggs were returned for incubation. On day 9th, gelatin sponges of size of 1 mm³ were placed on the top of growing CAM under sterile condition . The sponges were soaked with 10 μl of 50, 100 and 150 μM concentrations of heparin. Control CAM was treated with 10 μl of 1X PBS. The window was closed with a transparent adhesive tape and the eggs were returned for further incubation till day 12 (72hours) at which vascularization potential of the CAM reaches its maximum. The experimental groups were divided into 4 with each containing 40 numbers. Group1 represents 1X PBS (control), group 2, 3 and 4 corresponds to 10 μl of 50 μM, 100 μM and 150 μM of heparin. Treated CAM was photographed at 0, 24, 48 and 72hours using Cannon digital camera and the images were analyzed with Angioquant Toolbox, MATLAB 6.5 software to measure total length and size of blood vessels in micrometer at the area of treatment [12–14].
CAM treated with heparin was flooded with Bouin's fixative solution and the treated area was removed, dehydrated and embedded in paraffin wax. Vertical cross sections of 7 μm in thickness were taken using Rotary Microtome (Weswicox, Japan) . The histological sections were observed under Light Microscope at 40X magnification for qualitative assessment and images were taken using Nikon Camera attached with light microscope at 10X magnification.
Thickness of the CAM was measured from haematoxylin and eosin stained sections with a calibrated objective at 40X magnification using 10X10 calibrated grids in the 10X ocular. Each CAM was measured at 6 different locations from 6 serial cross sections of the same sample. To calculate mean tissue thickness (DCAM) all of the representative sections from the particular tissue sample were measured in micrometer and averaged to yield a mean CAM thickness .
Sections of CAM of 7 μM thickness were obtained using microtome after treatment with heparin. After 12hours of incubation at 37°C the sections were dewaxed. Sections were washed with 1X PBS and incubated with HRP conjugated streptavidin (HRP-anti-rabbit secondary) of 1:40 dilution for 1 hour at 37°C. After counterstaining with haematoxylin and eosin dehydration was performed with alcohol. Images were recorded after mounting with 90% of glycerol using Nikon camera attached with light microscope at 40X magnification. Immunohistochemical staining was performed on paraffin-embedded tissue sections with slight modifications.
Data analysis and statistics
All the experiments were performed in triplicate (n = 3) unless otherwise specified. Data are presented as mean ± SEM and were analyzed by One-Way ANOVA analysis of variance test, Student’s t-test and Tukey post hoc tests as appropriate by Sigma Stat 2.0. p = < 0.001 and p = 0.001 were considered as statistically significant.
Visualization of blood vessels on CAM
Qualitative assessment of angiogenic potential
Measurement of CAM thickness (DCAM)
Diffusion pattern of heparin
The present study reveals the mechanisms by which heparin of 15 kDa can induce angiogenesis in vitro. New blood vessel formation and its growth on CAM treated with heparin of varying concentrations implied that it has the potential to induce sprouting angiogenesis as observed in the increase in vessel length and size. The usage of Angioquant software to measure vessel growth in vivo is already reported by others. In sprouting angiogenesis activated Endothelial cells (ECs) favor binding of growth factors such as Vascular Endothelial Growth Factor (VEGF) and basic Fibroblast Growth Factor 2 (FGF2) with its specific receptors which could be activated by various external and internal stimulus  resulting in the degradation of extra cellular matrix by Matrix Metalloproteases (MMPs) and proliferation of ECs to form immature blood vessels . These immature blood vessels are further stabilized by the recruitment of mural cells which can contribute to the increase in the size of the vessels . It is understood that heparin could interact with these angiogenic growth factors [20, 21] and act as a mitogen for capillary ECs both in vivo and in vitro. Thus it could be concluded that heparin could induce sprouting angiogenesis on CAM and the growth pattern recorded at different time points showed that its action is dose-dependent with maximum efficacy at 100 μM after 72 hours of treatment.
It was proved that histology of the CAM changes as a response towards the biological materials placed on it including EC migration , fibroblast and mast cell accumulation [25, 26], changes in thickness of the epithelial layer, increase in the number of capillaries and capillary cords formation , presence of apoptotic ECs [27–30]. In the present study heparin is found to alter the morphology of those cells which have a direct role in angiogenesis similar to that reported earlier . The histological changes associated with 100 μM is suggestive of favo-ring blood vessel formation stronger than other two concentrations.
To calculate tissue thickness we measured the distance between chorionic and allantoic layers (in micrometer) that contains different kind of cells and any morphological change found in these cells could affect the entire structure of the CAM. An earlier study showed that angiogenic activity of the substance could be measured by calculating cell density of fibroblast, ECs and epithelial cells [15, 31]. Thickness of the CAM increases gradually during the early and mid phase of embryo growth due to the capillary migration from stroma region towards the inner shell membrane (ISM) . The ISM lies very close to the basal lamina which is the outer surface of the CAM where gelatin sponges soaked with heparin are implanted. The thickness of CAM treated with heparin had increased indicating the proliferation and growth of the blood vessels and can be concluded that heparin has the potential to induce new vessels formation with maximum performance at 100 μM concentration within 72hours.
It is already known that the angiogenic response of CAM depends on diffusion of test materials through the CAM thereby indicating its involvement in angiogenesis. We studied the diffusion pattern of biotinylated heparin and found that heparin had diffused through various layers of CAM. The affinity of biotin with streptavidin has made it useful for numerous bioanalytical and biotechnological applications [33–35] using CAM and mouse embryo assays . The diffusion pattern showed internalized action of heparin that could affect gene expression on endothelial cell and could stabilize, potentiate and transport growth factors which favor angiogenesis. This diffusion pattern was found to depend on the concentrations and implied the fact that though the higher concentration (150 μM) could favor new blood vessel formation up to certain extent might cause cellular damage. The diffusion of 100 μM heparin to the stroma region indicates that it would have a direct impact on angiogenesis and can favor sprouting of blood vessels.
The present study evaluates the effects of HMWH on formation of capillary-like tubular structures using CAM assay. UFH of 15 kDa enhances its formation in contrast to LMWH which is known to decrease the formation of tubular endothelial structures. Thus the present in ovo vivo study has demonstrated that heparin possesses the angiogenesis inducing affinity and is significant at 100 μM concentration. These data provide a novel mechanism by which higher molecular weight heparins can promote formation of capillary-like tubular structures and might be of therapeutic significance in inducing angiogenisis during wound healing process while the low molecular weight constituents can be employed to inhibit angiogenesis as in tumor progression.
This study was supported by University SAP sponsored programme and Merit fellowship, University Grant Commission, India.
- Berry D, Shriver Z, Natke B, Kwan CP, Venkataraman G, Sasisekharan R: Heparan sulphate glycosaminoglycans derived from endothelial cells and smooth muscle cells differentially modulate fibroblast growth factor-2 biological activity through fibroblast growth factor receptor-1. Biochem J. 2003, 373: 241-249. 10.1042/BJ20021760.PubMed CentralView ArticlePubMedGoogle Scholar
- Smorenburg SM, Van Noorden CJ: The complex effects of heparins on cancer progression and metastasis in experimental studies. Pharmacol Rev. 2001, 53: 93-105.PubMedGoogle Scholar
- Pacini S, Gulisano M, Vannucchi S, Ruggiero M: Poly-l-lysine/heparin stimulates angiogenesis in chick embryo chorioallantoic membrane. Biochem Biophys Res Commun. 2002, 290: 820-823. 10.1006/bbrc.2001.6254.View ArticlePubMedGoogle Scholar
- Zhang W, Chuang YJ, Swanson R, Li J, Seo K, Leung L, Lau LF, Olson ST: Antiangiogenic antithrombin down-regulates the expression of the proangiogenic heparan sulfate proteoglycan, perlecan, in endothelial cells. Blood. 2004, 103: 1185-1191.View ArticlePubMedGoogle Scholar
- Sasaki T, Larsson H, Kreuger J, Salmivirta M, Claesson-Welsh L, Lindahl U, Hohenester E, Timpl R: Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin. EMBO J. 1999, 18: 6240-6248. 10.1093/emboj/18.22.6240.PubMed CentralView ArticlePubMedGoogle Scholar
- Tiozzo R, Cingi MR, Croce MA: Interaction of heparan sulfate and its fractions with endothelial cells in culture. Int J Tissue React. 1993, 15: 163-168.PubMedGoogle Scholar
- Nissen NN, Shankar R, Gamelli RL, Singh A, DiPietro LA: Heparin and heparan sulphate protect basic fibroblast growth factor from non-enzymic glycosylation. Biochem J. 1999, 338 (Pt 3): 637-642.PubMed CentralView ArticlePubMedGoogle Scholar
- Taylor S, Folkman J: Protamine is an inhibitor of angiogenesis. Nature. 1982, 297: 1307-1912.View ArticleGoogle Scholar
- Ribatti D, Roncali L, Nico B, Bertossi M: Effects of exogenous heparin on the vasculogenesis of the chorioallantoic membrane. Acta Anat (Basel). 1987, 130: 257-263. 10.1159/000146454.View ArticleGoogle Scholar
- Pacini S, Gulisano M, Vannucchi S, Ruggiero M: Poly-L-lysine/Heparin Stimulates Angiogenesis in Chick Embryo Chorioallantoic Membrane. Biochem Biophys Res Commun. 2002, 290: 820-823. 10.1006/bbrc.2001.6254.View ArticlePubMedGoogle Scholar
- Ribatti D: Chick embryo chorioallantoic membrane as a useful tool to study angiogenesis. Int Rev Cell Mol Biol. 2008, 270: 181-224.View ArticlePubMedGoogle Scholar
- Niemisto A, Dunmire V, Yli-Harja O, Zhang W, Shmulevich I: Robust quantification of in vitro angiogenesis through image analysis. IEEE Trans Med Imaging. 2005, 24: 549-553.View ArticlePubMedGoogle Scholar
- Majumder S, Rajaram M, Muley A, Reddy HEPARIN, Tamilarasan KP, Kolluru GK, Sinha S, Siamwala JH, Gupta R, Ilavarasan R, Venkataraman S, Sivakumar KC, Anishetty S, Kumar PG, Chatterjee S: Thalidomide attenuates nitric oxide-driven angiogenesis by interacting with soluble guanylyl cyclase. Br J Pharmacol. 2009, 158: 1720-1734. 10.1111/j.1476-5381.2009.00446.x.PubMed CentralView ArticlePubMedGoogle Scholar
- Gopi Krishna K, Sinha S, Majumder S, Ajit M, Siamwala JH, Gupta R, Chatterjee S: Shear stress promotes nitric oxide production in endothelial cells by sub-cellular delocalization of eNOS: A basis for shear stress mediated angiogenesis. Nitric Oxide. 2010, 22: 304-315. 10.1016/j.niox.2010.02.004.View ArticleGoogle Scholar
- Yang EY, Moses HE: Transforming Growth Factor ß1- induced changes in cell Migration, Proliferation, and Angiogenesis in the chicken chorioallantoic membrane. The J Cell Biology. 1990, 111: 731-741. 10.1083/jcb.111.2.731.View ArticleGoogle Scholar
- Reizis A, Hammel I, Ar A: Regional and developmental variations of blood vessel morphometry in the chick embryo chorioallantoic membrane. J Exp Biol. 2005, 208: 2483-2488. 10.1242/jeb.01662.View ArticlePubMedGoogle Scholar
- Hillen F, Griffioen AW: Tumour vascularization: Sprouting angiogenesis and beyond. Cancer Metastasis Rev. 2007, 26: 489-502. 10.1007/s10555-007-9094-7.PubMed CentralView ArticlePubMedGoogle Scholar
- Ferrara N, Gerber HP, LeCouter J: The biology of vegf and its receptors. Nat Med. 2003, 9: 669-676. 10.1038/nm0603-669.View ArticlePubMedGoogle Scholar
- Jain RK: Molecular regulation of vessel maturation. Nat Med. 2003, 9: 685-693. 10.1038/nm0603-685.View ArticlePubMedGoogle Scholar
- Dudas J, Ramadori G, Knittel T, Neubauer K, Raddatz D, Egedy K, Kovalszky I: Effect of heparin and liver heparan sulphate on interaction of HepG2-derived transcription factors and their cis-acting elements: altered potential of hepatocellular carcinoma heparan sulphate. Biochem J. 2000, 350 (Pt 1): 245-251.PubMed CentralView ArticlePubMedGoogle Scholar
- Parish CR: The role of heparan sulphate in inflammation. Nat Rev Immunol. 2006, 6: 633-643. 10.1038/nri1918.View ArticlePubMedGoogle Scholar
- Risau W, Ekblom P: Production of a heparin-binding angiogenesis factor by the embryonic kidney. J Cell Biol. 1986, 103: 1101-1107. 10.1083/jcb.103.3.1101.View ArticlePubMedGoogle Scholar
- Swinscode JC, Carlson EC: Capillary endothelial cells secrete a heparin-binding mitogen for pericytes. J Cell Science. 1992, 103: 453-461.Google Scholar
- Mi-Sook L, Eun-Joung , Sae-Won L, Myoung Sook K, Kyu-Won K, Yung-Jin K: Angiogenic Activity of Pyruvic Acid inin Vivoandin VitroAngiogenesis Models. Cancer Res. 2001, 61: 3290-3293.Google Scholar
- Ribatti D, Vacca A, Giacchetta F, Cesaretti S, Anichini M, Roncali L, Damacco F: Lipoprotein (a) induces angiogenesis on the chick embryo chorioallantoic membrane. Eur J Clin Invest. 1998, 28: 533-537. 10.1046/j.1365-2362.1998.00322.x.View ArticlePubMedGoogle Scholar
- Ribatti D, Crivellato E, Candussio L, Nico B, Vacca A, Roncali L, Dammacco F: Mast cells and their secretory granules are angiogenic in the chick embryo chorioallantoic membrane. Clin Exp Allergy. 2001, 31: 602-608. 10.1046/j.1365-2222.2001.00986.x.View ArticlePubMedGoogle Scholar
- Rodriguez-Nieto S, Gonzalez-Iriarte M, Carmona R, Munoz-Chapuli R, Medina MA, Quesada AR: Antiangiogenic activity of aeroplysinin-1, a brominated compound isolated from a marine sponge. FASEB J. 2002, 16: 261-263.PubMedGoogle Scholar
- Giannopoulou E, Katsoris P, Kardamakis D, Papadimitriou E: Amifostine inhibits angiogenesis in vivo. J Pharmacol Exp Ther. 2003, 304: 729-737. 10.1124/jpet.102.042838.View ArticlePubMedGoogle Scholar
- Matschke K, Da Silva-Azevedo L, Hlushchuk R, Djonov V, Baum O: Annexins as cell-type-specific markers in the developing chicken chorionallantoic membrane. Cell Tissue Res. 2006, 323: 395-404. 10.1007/s00441-005-0112-1.View ArticlePubMedGoogle Scholar
- Balke M, Neumann A, Kersting C, Agelopoulos K, Gebert C, Gosheger G, Buerger H, Hagedorn M: Morphologic characterization of osteosarcoma growth on the chick chorioallantoic membrane. BMC Res Notes. 58-10.1186/1756-0500-3-58. 3Google Scholar
- Wilting J, Christ B, Bokeloh M: A modified chorioallantoic membrane (cam) assay for qualitative and quantitative study of growth factors. Anat Embryol (Berl). 1991, 183: 259-271.View ArticleGoogle Scholar
- Schlatter P, Konig MF, Karlsson LM, Burri PH: Quantitative study of intussusceptive capillary growth in the chorioallantoic membrane (cam) of the chicken embryo. Microvasc Res. 1997, 54: 65-73. 10.1006/mvre.1997.2022.View ArticlePubMedGoogle Scholar
- Mark Howarth, Daniel J-F Chinnapen, Kimberly Gerrow, Pieter C Dorrestein, Melanie R Grandy, Neil L Kelleher, Alaa El-Husseini &, Alice Y Ting: A monovalent streptavidin with a single femtomolar biotin binding site. Nature Methods. 2006, 3 (4): 267-273. 10.1038/nmeth861.View ArticleGoogle Scholar
- Joshua R, Wayment , Joel MH: Biotin-Avidin Binding Kinetics Measured by Single-Molecule Imaging. Anal Chem. 2009, 81: 336-342. 10.1021/ac801818t.View ArticleGoogle Scholar
- Zempleni J, Wijeratne SS, Hassan YI: Biotin. Biofactors. 2009, 35: 36-46. 10.1002/biof.8.View ArticlePubMedGoogle Scholar
- Fritzsch B: Fast axonal diffusion of 3000 molecular weight dextran amines. J Neurosci Methods. 1993, 50: 95-103. 10.1016/0165-0270(93)90060-5.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.